Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 69097-875

3 FDA label images from Cipla Usa Inc., · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 69097-875). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc.,, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (150mg 30tab)

Image Description (150mg 30tab)
The label for Bupropion Hydrochloride (XL) Extended-release 150 mg tablets by Cipla USA Inc. It shows 30 tablets per bottle, with warnings against use in combination with Zyban, dosage instructions for extended-release tablets, storage guidelines, and manufacturing details for InvaGen Pharmaceuticals and Cipla USA Inc. The label includes an NDC code 69097-875-02 and a QR code.*
FDA Label Image

Image Description (300mg 30tab)

Image Description (300mg 30tab)
Label for Bupropion Hydrochloride Extended-release Tablets USP (XL) 300 mg oral tablets by Cipla USA Inc. The carton contains 30 tablets. The label includes dosing and storage instructions, warnings about use with ZYBAN, and manufacturer information for InvaGen Pharmaceuticals, a Cipla subsidiary.*
FDA Label Image

Image Description (Bupropion Hydrochloride Sr 1)

Image Description (Bupropion Hydrochloride Sr 1)
Chemical structure diagram showing part of the bupropion hydrochloride molecule, including a chlorophenyl ring and chemical groups attached, representing the active ingredient bupropion hydrochloride used in Bupropion Hydrochloride (XL) tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.